nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinonide—SMO—Hedgehog Signaling Pathway—SUFU—malignant glioma	0.0695	0.127	CbGpPWpGaD
Fluocinonide—Condition aggravated—Temozolomide—malignant glioma	0.0509	0.251	CcSEcCtD
Fluocinonide—Cushing's syndrome—Carmustine—malignant glioma	0.0424	0.209	CcSEcCtD
Fluocinonide—SMO—embryo—malignant glioma	0.0396	0.162	CbGeAlD
Fluocinonide—SMO—Hedgehog signaling events mediated by Gli proteins—SUFU—malignant glioma	0.0289	0.0527	CbGpPWpGaD
Fluocinonide—SMO—medulla oblongata—malignant glioma	0.0253	0.103	CbGeAlD
Fluocinonide—SMO—Hedgehog signaling events mediated by Gli proteins—LGALS3—malignant glioma	0.0243	0.0444	CbGpPWpGaD
Fluocinonide—SMO—midbrain—malignant glioma	0.0232	0.0945	CbGeAlD
Fluocinonide—SMO—spinal cord—malignant glioma	0.0226	0.0922	CbGeAlD
Fluocinonide—SMO—central nervous system—malignant glioma	0.0183	0.0748	CbGeAlD
Fluocinonide—SMO—cerebellum—malignant glioma	0.0179	0.0731	CbGeAlD
Fluocinonide—SMO—Hedgehog 'off' state—SUFU—malignant glioma	0.0163	0.0298	CbGpPWpGaD
Fluocinonide—SMO—brain—malignant glioma	0.0146	0.0594	CbGeAlD
Fluocinonide—SMO—Signaling by Hedgehog—SUFU—malignant glioma	0.0145	0.0266	CbGpPWpGaD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—FGFR1—malignant glioma	0.0129	0.0236	CbGpPWpGaD
Fluocinonide—SMO—GPCRs, Other—CXCR3—malignant glioma	0.0118	0.0215	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.0113	0.0207	CbGpPWpGaD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—EGF—malignant glioma	0.0111	0.0203	CbGpPWpGaD
Fluocinonide—SERPINA6—central nervous system—malignant glioma	0.0101	0.0412	CbGeAlD
Fluocinonide—SERPINA6—cerebellum—malignant glioma	0.00987	0.0403	CbGeAlD
Fluocinonide—NR3C1—embryo—malignant glioma	0.00956	0.039	CbGeAlD
Fluocinonide—Skin exfoliation—Carmustine—malignant glioma	0.00918	0.0453	CcSEcCtD
Fluocinonide—Skin exfoliation—Temozolomide—malignant glioma	0.00887	0.0437	CcSEcCtD
Fluocinonide—NR3C1—brainstem—malignant glioma	0.00876	0.0358	CbGeAlD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.00857	0.0157	CbGpPWpGaD
Fluocinonide—SMO—Signaling events mediated by the Hedgehog family—PIK3CA—malignant glioma	0.00849	0.0155	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.00813	0.0148	CbGpPWpGaD
Fluocinonide—SERPINA6—brain—malignant glioma	0.00801	0.0327	CbGeAlD
Fluocinonide—Swelling—Carmustine—malignant glioma	0.00791	0.039	CcSEcCtD
Fluocinonide—NR3C1—telencephalon—malignant glioma	0.00778	0.0317	CbGeAlD
Fluocinonide—Nasal congestion—Temozolomide—malignant glioma	0.0074	0.0365	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.00724	0.0132	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—NF1—malignant glioma	0.00715	0.0131	CbGpPWpGaD
Fluocinonide—SMO—Signaling events mediated by the Hedgehog family—AKT1—malignant glioma	0.00694	0.0127	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.00662	0.0121	CbGpPWpGaD
Fluocinonide—Dry skin—Temozolomide—malignant glioma	0.00618	0.0305	CcSEcCtD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—MYC—malignant glioma	0.00618	0.0113	CbGpPWpGaD
Fluocinonide—NR3C1—medulla oblongata—malignant glioma	0.00611	0.0249	CbGeAlD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—malignant glioma	0.00605	0.011	CbGpPWpGaD
Fluocinonide—NR3C1—Signaling events mediated by HDAC Class II—YWHAE—malignant glioma	0.00581	0.0106	CbGpPWpGaD
Fluocinonide—NR3C1—midbrain—malignant glioma	0.00559	0.0228	CbGeAlD
Fluocinonide—NR3C1—spinal cord—malignant glioma	0.00545	0.0222	CbGeAlD
Fluocinonide—Hyperglycaemia—Carmustine—malignant glioma	0.00544	0.0268	CcSEcCtD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—malignant glioma	0.00542	0.00989	CbGpPWpGaD
Fluocinonide—Hyperglycaemia—Temozolomide—malignant glioma	0.00526	0.0259	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.00515	0.00941	CbGpPWpGaD
Fluocinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—malignant glioma	0.00503	0.00919	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.00479	0.00875	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.00475	0.00867	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MYB—malignant glioma	0.00475	0.00866	CbGpPWpGaD
Fluocinonide—NR3C1—Endoderm Differentiation—SOX2—malignant glioma	0.00469	0.00856	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—malignant glioma	0.00459	0.00839	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—malignant glioma	0.00458	0.00835	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CCR4—malignant glioma	0.00448	0.00819	CbGpPWpGaD
Fluocinonide—NR3C1—central nervous system—malignant glioma	0.00442	0.018	CbGeAlD
Fluocinonide—NR3C1—cerebellum—malignant glioma	0.00432	0.0176	CbGeAlD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.00431	0.00787	CbGpPWpGaD
Fluocinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—malignant glioma	0.00423	0.00772	CbGpPWpGaD
Fluocinonide—Immune system disorder—Temozolomide—malignant glioma	0.00421	0.0208	CcSEcCtD
Fluocinonide—Erythema—Carmustine—malignant glioma	0.0042	0.0207	CcSEcCtD
Fluocinonide—Erythema—Temozolomide—malignant glioma	0.00406	0.02	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.00385	0.00704	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog signaling events mediated by Gli proteins—AKT1—malignant glioma	0.00385	0.00703	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—LATS2—malignant glioma	0.00383	0.00699	CbGpPWpGaD
Fluocinonide—NR3C1—brain—malignant glioma	0.00351	0.0143	CbGeAlD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.00345	0.0063	CbGpPWpGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00343	0.0169	CcSEcCtD
Fluocinonide—Infection—Carmustine—malignant glioma	0.00341	0.0168	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.00334	0.00611	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CXCR3—malignant glioma	0.00333	0.00608	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.00331	0.00603	CbGpPWpGaD
Fluocinonide—Infection—Temozolomide—malignant glioma	0.00329	0.0162	CcSEcCtD
Fluocinonide—Nervous system disorder—Temozolomide—malignant glioma	0.00325	0.016	CcSEcCtD
Fluocinonide—Skin disorder—Temozolomide—malignant glioma	0.00322	0.0159	CcSEcCtD
Fluocinonide—NR3C1—Circadian Clock—NCOR1—malignant glioma	0.00308	0.00562	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—BDKRB2—malignant glioma	0.00305	0.00556	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptors—PPARG—malignant glioma	0.00297	0.00542	CbGpPWpGaD
Fluocinonide—Pain—Carmustine—malignant glioma	0.00293	0.0145	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—GJA1—malignant glioma	0.00293	0.00535	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—LATS1—malignant glioma	0.0029	0.0053	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—malignant glioma	0.00286	0.00522	CbGpPWpGaD
Fluocinonide—Pain—Temozolomide—malignant glioma	0.00283	0.014	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.00281	0.00514	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—KNG1—malignant glioma	0.00277	0.00506	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.00271	0.00495	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.00267	0.00488	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.00263	0.00481	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.00262	0.00479	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.0026	0.00474	CbGpPWpGaD
Fluocinonide—NR3C1—Circadian Clock—HIF1A—malignant glioma	0.0026	0.00474	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.00254	0.00464	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Carmustine—malignant glioma	0.00253	0.0125	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—MYB—malignant glioma	0.0025	0.00456	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Temozolomide—malignant glioma	0.00244	0.012	CcSEcCtD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—malignant glioma	0.00244	0.00446	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.00241	0.00441	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—malignant glioma	0.00238	0.00435	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.00236	0.0043	CbGpPWpGaD
Fluocinonide—Pruritus—Temozolomide—malignant glioma	0.00235	0.0116	CcSEcCtD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.00234	0.00428	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCR4—malignant glioma	0.0023	0.0042	CbGpPWpGaD
Fluocinonide—Dizziness—Carmustine—malignant glioma	0.00227	0.0112	CcSEcCtD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—malignant glioma	0.00226	0.00413	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—HLA-A—malignant glioma	0.00224	0.00409	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.00221	0.00404	CbGpPWpGaD
Fluocinonide—Dizziness—Temozolomide—malignant glioma	0.00219	0.0108	CcSEcCtD
Fluocinonide—Rash—Carmustine—malignant glioma	0.00216	0.0107	CcSEcCtD
Fluocinonide—Dermatitis—Carmustine—malignant glioma	0.00216	0.0107	CcSEcCtD
Fluocinonide—Headache—Carmustine—malignant glioma	0.00215	0.0106	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—HIF1A—malignant glioma	0.00214	0.00391	CbGpPWpGaD
Fluocinonide—Rash—Temozolomide—malignant glioma	0.00209	0.0103	CcSEcCtD
Fluocinonide—Dermatitis—Temozolomide—malignant glioma	0.00209	0.0103	CcSEcCtD
Fluocinonide—Headache—Temozolomide—malignant glioma	0.00208	0.0102	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.002	0.00365	CbGpPWpGaD
Fluocinonide—NR3C1—Endoderm Differentiation—NOTCH1—malignant glioma	0.00197	0.0036	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MDK—malignant glioma	0.00196	0.00358	CbGpPWpGaD
Fluocinonide—NR3C1—Endoderm Differentiation—APC—malignant glioma	0.00193	0.00352	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.00188	0.00343	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.00188	0.00343	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—DTX1—malignant glioma	0.00187	0.00342	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—MDM2—malignant glioma	0.00186	0.00339	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.00184	0.00336	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.0018	0.00329	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—F2—malignant glioma	0.00179	0.00327	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.00171	0.00313	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CXCR3—malignant glioma	0.00171	0.00312	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.0017	0.0031	CbGpPWpGaD
Fluocinonide—Triamcinolone—BCHE—malignant glioma	0.00167	0.379	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—BDKRB2—malignant glioma	0.00156	0.00286	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.00156	0.00285	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—NCOR1—malignant glioma	0.00155	0.00283	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.00154	0.00282	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CDKN2A—malignant glioma	0.00153	0.0028	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.00151	0.00276	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—IFNG—malignant glioma	0.00149	0.00273	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SUFU—malignant glioma	0.00149	0.00271	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HEY2—malignant glioma	0.00147	0.00268	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GFAP—malignant glioma	0.00143	0.00262	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—KNG1—malignant glioma	0.00142	0.0026	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CXCL8—malignant glioma	0.00139	0.00254	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SPHK1—malignant glioma	0.00139	0.00253	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HEY1—malignant glioma	0.00136	0.00248	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCR4—malignant glioma	0.00136	0.00248	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HES1—malignant glioma	0.00135	0.00246	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL2—malignant glioma	0.00133	0.00242	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HIST1H3B—malignant glioma	0.00132	0.00241	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—malignant glioma	0.00132	0.0024	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—malignant glioma	0.00131	0.00239	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—HIF1A—malignant glioma	0.0013	0.00238	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.00128	0.00233	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CXCL8—malignant glioma	0.00126	0.00231	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—MMP3—malignant glioma	0.00126	0.0023	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MMP9—malignant glioma	0.00126	0.00229	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—PTEN—malignant glioma	0.00125	0.00228	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—malignant glioma	0.00122	0.00223	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—JAG2—malignant glioma	0.00121	0.0022	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—malignant glioma	0.00117	0.00214	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.00113	0.00206	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—PPARG—malignant glioma	0.00111	0.00203	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	0.00104	0.0019	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MYC—malignant glioma	0.00104	0.00189	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—H3F3A—malignant glioma	0.00102	0.00186	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CXCR3—malignant glioma	0.00101	0.00184	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—YWHAE—malignant glioma	0.000983	0.00179	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NTRK2—malignant glioma	0.000983	0.00179	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FLT1—malignant glioma	0.000978	0.00179	CbGpPWpGaD
Fluocinonide—Dexamethasone—CYP2B6—malignant glioma	0.000975	0.221	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—DUSP6—malignant glioma	0.000974	0.00178	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—JAG1—malignant glioma	0.000962	0.00176	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NOTCH3—malignant glioma	0.000958	0.00175	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FBXW7—malignant glioma	0.000942	0.00172	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—BDKRB2—malignant glioma	0.000924	0.00169	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—malignant glioma	0.000923	0.00169	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—F2—malignant glioma	0.00092	0.00168	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CG—malignant glioma	0.00088	0.00161	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PTPN11—malignant glioma	0.000865	0.00158	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NOTCH2—malignant glioma	0.000859	0.00157	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TP53—malignant glioma	0.000852	0.00156	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—KNG1—malignant glioma	0.000841	0.00153	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AKT2—malignant glioma	0.000805	0.00147	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NTRK1—malignant glioma	0.000801	0.00146	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CD—malignant glioma	0.000774	0.00141	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NOTCH3—malignant glioma	0.000773	0.00141	CbGpPWpGaD
Fluocinonide—Triamcinolone—PTGS2—malignant glioma	0.00077	0.174	CrCbGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—malignant glioma	0.000751	0.00137	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MMP3—malignant glioma	0.000745	0.00136	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CDKN2B—malignant glioma	0.000738	0.00135	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000731	0.00134	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTK2—malignant glioma	0.000717	0.00131	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HES1—malignant glioma	0.000704	0.00129	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000702	0.00128	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NCOR1—malignant glioma	0.0007	0.00128	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.0007	0.00128	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NOTCH2—malignant glioma	0.000693	0.00127	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—RAF1—malignant glioma	0.000691	0.00126	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—STAT3—malignant glioma	0.000681	0.00124	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CB—malignant glioma	0.000674	0.00123	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PDGFRA—malignant glioma	0.000671	0.00122	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SPP1—malignant glioma	0.000651	0.00119	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CXCL8—malignant glioma	0.000648	0.00118	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—malignant glioma	0.00064	0.00117	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—malignant glioma	0.000634	0.00116	CbGpPWpGaD
Fluocinonide—Betamethasone—PTGS2—malignant glioma	0.00063	0.143	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—IL2—malignant glioma	0.000619	0.00113	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TERT—malignant glioma	0.000617	0.00113	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PDGFB—malignant glioma	0.000602	0.0011	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FGFR1—malignant glioma	0.000599	0.00109	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—CDKN2B—malignant glioma	0.000596	0.00109	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000594	0.00108	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HIF1A—malignant glioma	0.00059	0.00108	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TNF—malignant glioma	0.000589	0.00108	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CAV1—malignant glioma	0.000571	0.00104	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NCOR1—malignant glioma	0.000565	0.00103	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—KDR—malignant glioma	0.000564	0.00103	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—F2—malignant glioma	0.000543	0.000992	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FN1—malignant glioma	0.000543	0.000992	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—BAD—malignant glioma	0.000537	0.00098	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NOTCH1—malignant glioma	0.000532	0.000971	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—DNMT3B—malignant glioma	0.000528	0.000964	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CD80—malignant glioma	0.000521	0.000951	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APC—malignant glioma	0.00052	0.000949	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CG—malignant glioma	0.00052	0.000949	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EGF—malignant glioma	0.000514	0.000938	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—HIST1H3B—malignant glioma	0.000513	0.000937	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTPN11—malignant glioma	0.000511	0.000933	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000509	0.00093	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—BRAF—malignant glioma	0.000489	0.000892	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AKT2—malignant glioma	0.000476	0.000869	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—EGFR—malignant glioma	0.000474	0.000865	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CD—malignant glioma	0.000457	0.000835	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—KRAS—malignant glioma	0.000448	0.000817	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FGF2—malignant glioma	0.000438	0.000799	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000429	0.000784	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CA—malignant glioma	0.000411	0.000751	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MDM2—malignant glioma	0.000409	0.000748	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—RAF1—malignant glioma	0.000408	0.000745	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—PPARG—malignant glioma	0.000405	0.00074	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ERBB2—malignant glioma	0.000404	0.000737	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CB—malignant glioma	0.000398	0.000727	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—H3F3A—malignant glioma	0.000396	0.000724	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CXCL8—malignant glioma	0.000383	0.000699	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NOTCH3—malignant glioma	0.000372	0.000679	CbGpPWpGaD
Fluocinonide—Dexamethasone—PTGS2—malignant glioma	0.000367	0.0831	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—CASP3—malignant glioma	0.000366	0.000669	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL2—malignant glioma	0.000366	0.000668	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MMP9—malignant glioma	0.000346	0.000632	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTEN—malignant glioma	0.000344	0.000629	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AKT1—malignant glioma	0.000336	0.000613	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NOTCH2—malignant glioma	0.000334	0.000609	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—VEGFA—malignant glioma	0.000311	0.000568	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—STAT3—malignant glioma	0.000308	0.000562	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—CDKN2B—malignant glioma	0.000287	0.000524	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MYC—malignant glioma	0.000286	0.000522	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EGFR—malignant glioma	0.00028	0.000511	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NCOR1—malignant glioma	0.000272	0.000497	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—KRAS—malignant glioma	0.000264	0.000483	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CA—malignant glioma	0.000243	0.000443	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TP53—malignant glioma	0.000235	0.000429	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—MYC—malignant glioma	0.000231	0.000422	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NOTCH1—malignant glioma	0.000207	0.000377	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AKT1—malignant glioma	0.000198	0.000362	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PPARG—malignant glioma	0.000195	0.000356	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—MYC—malignant glioma	0.000111	0.000203	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—AKT1—malignant glioma	7.71e-05	0.000141	CbGpPWpGaD
